Hutchmed (China) Limited (HCM) ORD USD0.10
- Add to watchlist
- Create an alert
- This stock can be held in a
266.50p
273.00p
338.00p
£2.28 bn
264.50p
261.51p
173.60p
27.81
0.50p (0.19%) Previous:
0.50p
18,840
n/a
2,000
Performance
1 week 1W | 2.4% | 1 year 1Y | 16.52% |
---|---|---|---|
1 month 1M | 6.44% | 2 years 2Y | 6.62% |
3 months 3M | 2.22% | 3 years 3Y | 32.18% |
6 months 6M | 5.37% | 5 years 5Y | 40.23% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 838.00 | 426.41 |
Profit before tax ($m) | 58.31 | (410.42) |
Adjusted EPS (¢): | 12.00 | (43.00) |
P/E ratio | 29.80 | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Hutchmed cancer treatment indication accepted for review in China
28 March 2024 13:02
-
Hutchmed partner Inmagene exercises options over two drug candidates
2 February 2024 09:42
-
Hutchmed's 'Elunate' approved under new Hong Kong rules
30 January 2024 10:32
-
LTIP and Share Option Scheme
14 March 2024 09:00
-
Vesting of awards under the LTIP
5 March 2024 08:30
-
2023 Full Year Results and Business Updates
28 February 2024 11:30
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.